Table 2.
Variables | Starter | Add-on | Monotherapy | Total sample |
---|---|---|---|---|
n= 10 (20%) | n= 29 (58%) | n= 11(22%) | n=50 | |
CGI-S baseline | 4.0± 0.66 | 4.13±0.63 | 3.8±0.87 | 4.04±0.69 |
CGI-S end of treatment | 1.7±0.94 | 2.75±1.2 | 2.27±1.34 | 2.44±1.24 |
CGI-I end of treatment | 1.5±0.7* | 2.48±0.98 | 2.1±1.13 | 2.2±1.03 |
Global Improvement (y/n) | 10 (100%), 0 (0%) | 24 (82.8%); 5 (17.2%) | 9 (81.8%); 2 (18.2%) | 43 (86%); 7 (14%) |
Global Improvement | ||||
Very much improved | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Much improved | 6 (40%) | 5 (33.3%) | 4 (26.7%) | 15 (30%) |
Minimally improved | 4 (14.3%) | 19 (67.9%) | 5 (17.3%) | 28 (56%) |
No change from baseline | 0 (0%) | 5(71.4%) | 2 (28.6%) | 7 (14%) |
Minimally worse | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Much worse | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Very much worse | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Notes: Values for categorical and continuous variables are expressed in percentages and mean ± SD, respectively. CGI-S: Clinical Global Impression-Severity; CGI-I: Clinical Global Impression-Improvement. Boldface indicates parameters with statistically significant differences between subgroups. **p<0.001 *p<0.05